Rafferty Asset Management, LLC Summit Therapeutics Inc. Transaction History
Rafferty Asset Management, LLC
- $27.6 Billion
- Q4 2024
A detailed history of Rafferty Asset Management, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 311,692 shares of SMMT stock, worth $5.78 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
311,692
Previous 108,315
187.76%
Holding current value
$5.78 Million
Previous $2.37 Million
134.53%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$453 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$216 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$146 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$122 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$104 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.73B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...